Skip to main content
DAVITA INC. logo

DAVITA INC. — Investor Relations & Filings

Ticker · DVA ISIN · US23918K1088 LEI · M2XHYMU3TZNEZURC6H66 US Human health and social work activities
Open in API
Filings indexed 2,061 across all filing types
Latest filing 2023-04-25 Annual Report
Country US United States of America
Listing US DVA

About DAVITA INC.

https://www.davita.com/

DaVita Inc. is a healthcare provider specializing in kidney care services. The company offers a range of treatments for patients with chronic kidney disease and end-stage kidney disease, primarily through a network of outpatient dialysis centers. Its core service is providing life-sustaining dialysis, including in-center hemodialysis and peritoneal dialysis. In addition to clinical treatments, DaVita provides integrated health care management and extensive patient support. This includes educational resources, tools, and dietary guidance to help individuals manage their kidney health throughout their entire disease journey. The company focuses on delivering holistic and equitable care to improve the quality of life for its patients.

Recent filings

Filing Released Lang Actions
ANNUAL REPORT TO SECURITY HOLDERS
Annual Report
2023-04-25 English
DEFA14A
Proxy Solicitation & Information Statement Classification · 95% confidence The document is identified as a Schedule 14A filing, which is a proxy statement or related materials filed pursuant to Section 14(a) of the Securities Exchange Act of 1934. The text explicitly states it is a "Definitive Additional Materials" related to a proxy statement for DaVita Inc. Proxy statements and related materials are used to solicit shareholder votes and provide information for meetings. This matches the definition of Proxy Solicitation & Information Statement (PSI). The document length is short (2039 characters), and it is not an announcement of a report but the proxy materials themselves. Therefore, the correct classification is PSI with high confidence.
2023-04-25 English
DEF 14A
Proxy Solicitation & Information Statement
2023-04-25 English
PRE 14A
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a Schedule 14A Proxy Statement filed with the SEC, specifically identified as a Preliminary Proxy Statement for DaVita Inc.'s 2023 Annual Meeting of Stockholders. It includes detailed information about the meeting agenda, board composition, corporate governance, executive compensation, and voting matters. Proxy Statements (Schedule 14A) are materials sent to shareholders to provide information and solicit votes for meetings. This matches the definition of Proxy Solicitation & Information Statement (PSI). The document is lengthy (15,000 characters) and contains substantive content typical of a proxy statement, not just an announcement or a brief notice. Therefore, the correct classification is PSI with high confidence.
2023-04-14 English
Jahresabschluss zum Geschäftsjahr vom 01.01.2021 bis zum 31.12.2021
Annual Report Classification · 100% confidence The document is a 'Jahresabschluss' (Annual Financial Statement) for DaVita Deutschland AG for the fiscal year 2021. It contains a balance sheet (Bilanz), profit and loss statement (Gewinn- und Verlustrechnung), and notes (Anhang). This constitutes a comprehensive annual financial report, which falls under the 10-K category for annual reporting. FY 2021
2023-04-14 German
FORM 4
Director's Dealing
2023-04-06 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.